Year Ended

(in thousands, except per share amounts)

December 31, 2022

December 31, 2021

Net loss

$

(13,263)

$

(282,242)

Less: Net income attributable to Enfusion, Inc. prior to the IPO

-

(12,892)

Less: Net loss attributable to non-controlling interests

5,609

123,925

Net loss attributable to Enfusion, Inc.

$

(7,654)

$

(171,209)

Numerator:

Net loss attributable to Enfusion, Inc.

$

(7,654)

$

(171,209)

Adjustment to loss attributable to common stockholders

(954)

(16,580)

Numerator for Basic and Diluted Earnings per Share

$

(8,608)

$

(187,789)

Denominator:

Weighted-average shares of Class A common stock outstanding

67,057

65,583

Vested shares of Class A common stock and RSUs

18,336

17,462

Weighted-average shares of Class A common stock outstanding--basic and diluted

85,393

83,045

Net loss per share of Class A common stock--Basic and diluted

$

(0.10)

$

(2.26)